Bladder Cancer
2025 ESMO Bladder Cancer Highlights
Bladder Cancer Conference Highlights from ASCO GU 2025
Bladder Cancer Updates - GU Oncology Cancer Highlights: ESMO 2024
Bladder Cancer Highlights presented by Michael Serzan, MD
Bladder Conditions: Diagnosis, Referral and Treatment
ASCO 2023: Bladder Cancer Highlights Presented By Charlene Mantia, MD
Bladder Cancer in Women | Q&A with A Urologic Oncologist
JHGBCI Virtual Grand Rounds | Upper Tract Urothelial Cancer: It's a Team Effort
JHGBCI Virtual Grand Rounds | It's All Related: Kidney Health for Bladder Cancer Patients
2022 GU ASCO Bladder Cancer Highlights
Urologist Bladder Cancer Q&A | Max Kates, M.D.
Bladder Cancer Research at ESMO
Robot-Assisted Surgery for Gastroesophageal Cancers is Transforming Patient Outcomes
Bladder Cancer Advances
New Treatments for Bladder Cancer Patients
Impact of FGFR2/3 Activating Genomic Alterations on Response to Enfortumab Vedotin in Metastatic Urothelial Carcinoma (mUC)
An Open-Label, Multicenter, Phase IIIb Study of Patients with Urinary Tract Carcinoma (UTC) (STRONG): Final Analysis for Fixed-Dose Durvalumab Monotherapy (Module A)
Advances in Treating Women’s Bladder Cancer
Showing 1 - 18 of 32 results
Previous| 1 | 2 |Next
Cancer
Cardiology
Gastroenterology
Neurology
OBGYN
Orthopedics
Pediatrics
BroadcastMed News
Dermatology
Diabetes & Endocrinology
Infectious Diseases
Ophthalmology
Optometry
Otolaryngology
Pulmonology
Surgery
Urology
About
Solutions
Resources
Contact
person Sign In / Create Account
